Ophthalmic device with thin film nanocrystal integrated circuits

US9429769B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9429769-B2
Application numberUS-201313891166-A
CountryUS
Kind codeB2
Filing dateMay 9, 2013
Priority dateMay 9, 2013
Publication dateAug 30, 2016
Grant dateAug 30, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention discloses methods and apparatus to form Thin Film Nanocrystal Integrated Circuit transistors upon Three-dimensionally Formed Insert Pieces. In some embodiments, the present invention includes incorporating the Three-dimensional Surfaces with Thin Film Nanocrystal Integrated Circuit based thin film transistors, electrical interconnects, and energization elements into an Insert Piece for incorporation into Ophthalmic Device. In some embodiments, the Insert Piece may be directly used as a Media Insert or incorporated into an Ophthalmic Device.

First claim

Opening claim text (preview).

The invention claimed is: 1. An ophthalmic device comprising: a first media insert comprising an active optical device, a first thin film nanocrystal transistor, a first energization element and a first conductive trace, wherein the first thin film nanocrystal transistor comprises an n-type nanocrystal layer, wherein the first energization element is proximate to the first conductive trace so that the first energization element is in electrical communication with the first thin film nanocrystal transistor, wherein the active optical device comprises a liquid meniscus lens element having two immiscible fluids forming a meniscus therebetween, wherein the active optical device is in electrical communication with the first energization element and the first thin film nanocrystal transistor, and wherein the active optical device is configured to change the focal characteristics of the ophthalmic device upon application of an electrical charge to change the shape of the meniscus; and a hydrogel material surrounding or encapsulating the first media insert. 2. The ophthalmic device of claim 1 , wherein the first thin film nanocrystal transistor comprises a p-type nanocrystal layer. 3. The ophthalmic device of claim 1 , wherein the first conductive trace comprises a transparent electrode. 4. The ophthalmic device of claim 1 , wherein the first energization element comprises a plurality of electrochemical cells, wherein the electrochemical cells are in connection at least in part in a series. 5. The ophthalmic device of claim 1 , wherein the first media insert further comprises an activation element in electrical communication with the active optical device. 6. The ophthalmic device of claim 1 , wherein the n-type nanocrystal layer comprises cadmium selenide nanocrystals. 7. The ophthalmic device of claim 1 , wherein the first media insert further comprises a second thin film transistor comprising a second nanocrystal layer, wherein the second thin film transistor is in electrical communication with the first energization element. 8. The ophthalmic device of claim 2 , wherein the p-type nanocrystal layer comprises copper selenide. 9. The ophthalmic device of claim 3 , wherein the transparent electrode comprises indium tin oxide. 10. The ophthalmic device of claim 5 , wherein the activation element comprises a pressure sensitive switch. 11. The ophthalmic device of claim 7 , wherein the second thin film transistor comprises a p-type nanocrystal layer. 12. The ophthalmic device of claim 11 , wherein the p-type nanocrystal layer of the second thin film transistor comprises copper selenide. 13. The ophthalmic device of claim 7 , additionally comprising a second media insert comprising: a second energization element; a second conductive trace; and a third thin film transistor comprising an organic semiconductor layer, wherein the second conductive trace is capable of placing the second energization element in electrical communication with the third thin film transistor. 14. The ophthalmic device of claim 13 , wherein the third thin film transistor comprises an n-type nanocrystal layer. 15. The ophthalmic device of claim 14 , wherein the n-type nanocrystal layer comprises cadmium selenide nanocrystals. 16. The ophthalmic device of claim 13 , additionally comprising a fourth thin film transistor, wherein the fourth thin film transistor comprises a p-type organic semiconductor layer. 17. The ophthalmic device of claim 16 , wherein the p-type organic semiconductor layer comprises pentacene. 18. The ophthalmic device of claim 1 , wherein the first media insert has a three-dimensional topography. 19. The ophthalmic device of claim 1 , wherein the first energization element is configured to energize a circuit that includes the first thin film nanocrystal transistor and a second thin film transistor, the first thin film nanocrystal transistor comprising an n-type nanocrystal layer and the second thin film transistor comprising a p-type nanocrystal layer. 20. The ophthalmic device of claim 19 , wherein the circuit is configured to permit the ophthalmic device to turn on and off. 21. The ophthalmic device of claim 1 , wherein the first thin film nanocrystal transistor comprises a gate electrode, a nanocrystal layer, a gate dielectric layer between the gate electrode and the nanocrystal layer, a source electrode in contact with the nanocrystal layer, and a drain electrode in contact with the nanocrystal layer. 22. An ophthalmic device comprising: a first media insert having a three-dimensional surface, wherein first the media insert comprises at least a first thin film nanocrystal transistor, a first energization element and a first conductive trace, wherein the first thin film nanocrystal transistor comprises a n-type nanocrystal layer, and wherein the first energization element is proximate to the first conductive trace so that it is in electrical communication with the first thin film nanocrystal transistor; and a hydrogel material surrounding or encapsulating the first media insert. 23. The ophthalmic device of claim 22 , wherein the first thin film nanocrystal transistor comprises a p-type nanocrystal layer. 24. The ophthalmic device of claim 22 , wherein the first conductive trace comprises a transparent electrode. 25. The ophthalmic device of claim 22 , wherein the first energization element comprises a plurality of electrochemical cells, wherein the electrochemical cells are in connection at least in part in a series. 26. The ophthalmic device of claim 22 , wherein the first media insert additionally comprises an active optical device capable of changing the focal characteristics of the ophthalmic device, wherein the active optical device is in electrical communication with the first energization element. 27. The ophthalmic device of claim 26 , wherein the active optical device comprises a liquid meniscus lens element having two immiscible fluids forming a meniscus therebetween, and wherein the active optical device is configured to change the focal characteristics of the ophthalmic device upon application of an electrical charge to change the shape of the meniscus. 28. The ophthalmic device of claim 26 , wherein the first media insert further comprises an activation element in electrical communication with the active optical device. 29. The ophthalmic device of claim 22 , wherein the n-type nanocrystal layer comprises cadmium selenide nanocrystals. 30. The ophthalmic device of claim 22 , wherein the first media insert additionally comprises a second thin film transistor comprising a second nanocrystal layer, wherein the second thin film transistor is in electrical communication with the first energization element. 31. The ophthalmic device of claim 24 , wherein the transparent electrode comprises indium tin oxide. 32. The ophthalmic device of claim 28 , wherein the activation element comprises a pressure sensitive switch. 33. The ophthalmic device of claim 30 , wherein the second thin film transistor comprises a p-type nanocrystal layer. 34. The ophthalmic device of claim 33 , wherein the p-type nanocrystal layer of the second thin film transistor comprises copper selenide. 35. The ophthalmic device of claim 30 , additionally compris

Assignees

Inventors

Classifications

  • Package configurations · CPC title

  • Arrangements for protection of devices (arrangements for thermal protection H10W40/00) · CPC title

  • Electricity · mapped topic

  • Electricity · mapped topic

  • Electricity · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9429769B2 cover?
This invention discloses methods and apparatus to form Thin Film Nanocrystal Integrated Circuit transistors upon Three-dimensionally Formed Insert Pieces. In some embodiments, the present invention includes incorporating the Three-dimensional Surfaces with Thin Film Nanocrystal Integrated Circuit based thin film transistors, electrical interconnects, and energization elements into an Insert Pie…
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification B29D11/00817. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).